Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6892481 | 0.71 | EPHX1 (0.32) | — | |
| SCHEMBL12855833 | 0.69 | — | — | |
| SCHEMBL14098658 | 0.67 | — | — | |
| SCHEMBL10993285 | 0.67 | — | — | |
| SCHEMBL2077473 | 0.65 | TDP1 (0.32) | — | |
| SCHEMBL2074745 | 0.65 | — | — | |
| SCHEMBL1172663 | 0.65 | — | — | |
| SCHEMBL267114 | 0.65 | — | — | |
| SCHEMBL4543694 | 0.65 | — | — | |
| SCHEMBL813272 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11549020-B2 | Curable composition for nano-fabrication | CANON KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20210087407-A1 | Curable Composition for Nano-Fabrication | CANON KABUSHIKI KAISHA (JP) | 2021-03-25 | — | — | US | disclosed |
| US-7807845-B2 | Resistance-repellent retroviral protease inhibitors | SEQUOIA PHARMACEUTICALS, INC. (US) | 2010-10-05 | — | — | US | disclosed |
| US-7507763-B2 | Resistance-repellent retroviral protease inhibitors | SEQUOIA PHARMACEUTICALS (US) | 2009-03-24 | — | — | US | disclosed |
| EP-1422254-B1 | Photocationic polymerization initiator and photocationically polymerizable composition | TOKUYAMA CORP (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-7378441-B2 | Resistance-repellent retroviral protease inhibitors | SEQUOIA PHARMACEUTICALS, INC. (US) | 2008-05-27 | — | — | US | disclosed |
| US-7285566-B2 | Resistance-repellent retroviral protease inhibitors | SEQUOIA PHARMACEUTICALS, INC. | 2007-10-23 | — | — | US | disclosed |
| EP-1431315-B1 | Photopolymerization initiator and photopolymerizable composition | TOKUYAMA CORP (JP) | 2007-10-17 | — | — | EP | disclosed |
| EP-0341551-B1 | ALKENOIC ACID DERIVATIVES | BAYER AG (DE) | 1992-04-01 | — | — | EP | disclosed |
| US-5053551-A | PROCESS FOR THE PRODUCTION OF ALDEHYDES BY HYDROFORMYLATION | DAVY MCKEE (LONDON) LIMITED (GB) | 1991-10-01 | — | — | US | disclosed |
| EP-0313559-B1 | PROCESS FOR THE PRODUCTION OF ALDEHYDES BY HYDROFORMYLATION | DAVY McKEE (LONDON) LIMITED (GB) | 1991-08-28 | — | — | EP | disclosed |
| EP-0341551-A1 | Alkenoic acid derivatives | BAYER AG (DE) | 1989-11-15 | — | — | EP | disclosed |
| EP-0313559-A1 | PROCESS FOR THE PRODUCTION OF ALDEHYDES BY HYDROFORMYLATION. | DAVY MCKEE LONDON (GB) | 1989-05-03 | — | — | EP | disclosed |